Nonadherence to anti-TNF therapy predicts clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study

被引：0
|
作者：
van der Have, M. [1 ]
Oldenburg, B. [1 ]
Kaptein, A. A. [2 ]
Jansen, J. M. [3 ]
Scheffer, R. C. [4 ]
van Tuyl, S. A. [5 ]
van der Meulen-de Jong, A. E. [6 ]
Pierik, M. [7 ]
Siersema, P. D. [1 ]
van Oijen, M. G. [1 ,8 ]
Fidder, H. H. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[2] Leiden Univ, Med Ctr, Sect Med Psychol, Leiden, Netherlands
[3] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[4] Jeroen Bosch Hosp, Dept Gastroenterol & Hepatol, Shertogenbosch, Netherlands
[5] Diakonessen Hosp, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[6] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands
[7] Maastricht Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-6200 MD Maastricht, Netherlands
[8] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP043
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [41] AN AUDIT OF ADHERENCE TO ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Duncan, J.
    Sastrillo, M.
    Baker, J.
    Younge, L.
    Anderson, S.
    Lindsay, J.
    Sanderson, J.
    Irving, P.
    GUT, 2011, 60
  • [42] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    José Miranda-Bautista
    Celia de Gracia-Fernández
    María López-Ibáñez
    María Barrientos
    Alejandra Gallo-Moltó
    Marina González-Arias
    Casilda González-Gil
    Alicia Díaz-Redondo
    Ignacio Marín-Jiménez
    Luis Menchén
    Digestive Diseases and Sciences, 2015, 60 : 2130 - 2135
  • [43] Anti-TNF therapy successfully improves anemia in Inflammatory Bowel Disease - Results from a tertiary referral center
    Moura, M.
    Fernandes, S.
    Sousa, P.
    Santos, P.
    Baldaia, C.
    Goncalves, A. R.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Serejo, F.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S308 - S308
  • [44] Clinical features and outcomes of tuberculosis in inflammatory bowel disease patients treated with anti-TNF therapy as compared with the general population
    Kim, J.
    Im, J. P.
    Yim, J-J
    Lee, C. K.
    Park, D. I.
    Eun, C. S.
    Jung, S-A
    Shin, J. E.
    Lee, K-M
    Cheon, J. H.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S353 - S353
  • [45] Anti-TNF therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes
    Garrouste, Cyril
    Anglicheau, Dany
    Kamar, Nassim
    Bachelier, Claire
    Rivalan, Joseph
    Pereira, Bruno
    Caillard, Sophie
    Aniort, Julien
    Gatault, Philippe
    Soubrier, Martin
    Sayegh, Johnny
    Colosio, Charlotte
    Buisson, Anthony
    Thervet, Eric
    Bouvier, Nicolas
    Heng, Anne Elisabeth
    MEDICINE, 2016, 95 (41)
  • [46] Clinical features and outcomes of tuberculosis in inflammatory bowel disease patients treated with anti-TNF therapy as compared with the general population
    Kim, Jihye
    Im, Jong Pil
    Yim, Jae-Joon
    Lee, Chang Kyun
    Park, Dong Il
    Eun, Chang Soo
    Jung, Sung-Ae
    Shin, Jeong Eun
    Lee, Kang-Moon
    Cheon, Jae Hee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 183 - 183
  • [47] Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
    Chanchlani, Neil
    Lin, Simeng
    Auth, Marcus K.
    Lee, Chai Leng
    Robbins, Helena
    Looi, Shi
    Murugesan, Senthil, V
    Riley, Tom
    Preston, Cathryn
    Stephenson, Sophie
    Cardozo, Wendy
    Sonwalkar, Sunil A.
    Allah-Ditta, Mohammed
    Mansfield, Lynne
    Durai, Dharmaraj
    Baker, Mark
    London, Ian
    London, Emily
    Gupta, Sanjay
    Di Mambro, Alex
    Murphy, Aisling
    Gaynor, Edward
    Jones, Kelsey D. J.
    Claridge, Andrew
    Sebastian, Shaji
    Ramachandran, Sankaranarayanan
    Selinger, Christian P.
    Borg-Bartolo, Simon P.
    Knight, Paul
    Sprakes, Michael B.
    Burton, Julie
    Kane, Patricia
    Lupton, Stephanie
    Fletcher, Aimee
    Gaya, Daniel R.
    Colbert, Roghan
    Seenan, John Paul
    MacDonald, Jonathan
    Lynch, Lucy
    McLachlan, Iain
    Shields, Stephanie
    Hansen, Richard
    Gervais, Lisa
    Jere, Mwansa
    Akhtar, Muhammad
    Black, Karen
    Henderson, Paul
    Russell, Richard K.
    Lees, Charlie W.
    Derikx, Lauranne A. A. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1250 - 1263
  • [48] Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study
    Stein, Ronen
    Turner, Dan
    Hussey, Seamus
    Kawasmi, Aysha
    Ledder, Oren
    Levine, Jeremiah
    Markowitz, James
    Matar, Manar
    Orlanski-Meyer, Esther
    Russell, Richard K.
    Shaoul, Ron
    Yerushalmy-Feler, Anat
    Mould, Diane R.
    Conrad, Maire A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (06) : 1000 - 1010
  • [49] DISPARITIES IN CLINICAL OUTCOMES IN AFRICAN AMERICAN OUTPATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY
    Dalsania, Raj
    Gardner, Doree
    Ward, Angela
    Rutherford, Robin
    Dhere, Tanvi A.
    Iskandar, Heba
    GASTROENTEROLOGY, 2017, 152 (05) : S441 - S442
  • [50] Maternal and foetal outcomes after anti-TNF therapy in inflammatory bowel diseases
    Subramaniam, K.
    Hampe, T.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 96 - 96
12345